The following are the most important diseases or complications that may be contributed to by Conn syndrome:
Endocrine, nutritional, and metabolic diseases (E00-E90).
- Diabetes mellitus type 2
- Dyslipidemia (lipid metabolism disorder)
- Metabolic syndrome – clinical name for the symptom combination obesity (overweight), hypertension (high blood pressure), increased fasting glucose (fasting blood sugar) and fasting insulin serum levels (insulin resistance) and dyslipidemia (increased VLDL triglycerides, decreased HDL cholesterol). Furthermore, a coagulation disorder (increased tendency to clotting), with an increased risk of thromboembolism can often be detected.
Cardiovascular system (I00-I99)
- Apoplexy (stroke)
- Hypertension (high blood pressure)-manifestation in the classic constellation of hypertension and spontaneous hypokalemia (potassium deficiency); also frequently seen as normokalemic hypertension (most common cause of secondary hypertension)
- A study included a total of 1,672 primary care patients with hypertension (569 newly diagnosed and 1,103 patients previously diagnosed with arterial hypertension:
- 99 patients (5.9%) were diagnosed with primary hyperaldosteronism (PA; Conn syndrome)
- Overall prevalence (disease incidence) of PA increased with severity of hypertension, from 3.9% in stage I to 11.8% in stage III hypertension
- A study included a total of 1,672 primary care patients with hypertension (569 newly diagnosed and 1,103 patients previously diagnosed with arterial hypertension:
- Cardiovascular damage, unspecified.
- Myocardial infarction (heart attack)
- Atrial fibrillation (VHF)
Genitourinary system (kidneys, urinary tract – reproductive organs) (N00-N99)
- Proteinuria (increased excretion of protein in the urine).
- Renal failure
Further
